Analytical Data
-
基因名
Acrp30
- Application
-
别名
Acrp30；ACDC；ACRP30；APM1；Adiponectin
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q15848
-
表达区间
19-244aa
-
氨基酸序列
ETTTQGPGVLLPLPKGACTGWMAGIPGHPGHNGAPGRDGRDGTPGEKGEK GDPGLIGPKGDIGETGVPGAEGPRGFPGIQGRKGEPGEGAYVYRSAFSVG LETYVTIPNMPIRFTKIFYNQQNHYDGSTGKFHCNIPGLYYFAYHITVYM KDVKVSLFKKDKAMLFTYDQYQENNVDQASGSVLLHLEVGDQVWLQVYGE GERNGLYADNDNDSTFTGFLLYHDTN
-
分子量
25 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Acrp30, also known as adiponectin, is a protein primarily produced by adipose tissue and plays a crucial role in regulating glucose levels as well as fatty acid breakdown. It exists in several forms, with the full-length protein and its globular domain being of particular interest in scientific research. The physiological significance of Acrp30 lies in its anti-inflammatory and insulin-sensitizing properties, making it a focal point in studies related to obesity, type 2 diabetes, and cardiovascular diseases. Research has demonstrated that low circulating levels of Acrp30 are associated with metabolic disorders, and increasing its levels may exert beneficial effects on metabolic health. Due to its involvement in these key metabolic pathways, recombinant Acrp30 proteins have garnered attention for their potential use in therapeutic interventions. Furthermore, the study of Acrp30’s mechanisms of action can unravel new insights into adipose tissue function, offering promising avenues for treating obesity-related conditions. Thus, the production and characterization of recombinant Acrp30 have significant implications in biomedical research, aiming to develop innovative strategies for enhancing metabolic health and preventing associated diseases.
